Healthcare provider profile · identity verified

Haritha Boppana, MD

Internal Medicine · GREENVILLE, SC · NPI 1750386454

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	404	49
Furosemide	Furosemide	342	57
Atorvastatin Calcium	Atorvastatin Calcium	306	80
Amlodipine Besylate	Amlodipine Besylate	247	57
Eliquis	Apixaban	242	49
Mirtazapine	Mirtazapine	157	36
Metoprolol Succinate	Metoprolol Succinate	148	43
Potassium Chloride	Potassium Chloride	145	40
Tamsulosin Hcl	Tamsulosin Hcl	142	35
Carvedilol	Carvedilol	140	31
Gabapentin	Gabapentin	139	35
Lisinopril	Lisinopril	138	28
Memantine Hcl	Memantine Hcl	130	20
Divalproex Sodium	Divalproex Sodium	128	30
Escitalopram Oxalate	Escitalopram Oxalate	115	33
Omeprazole	Omeprazole	111	39
Sertraline Hcl	Sertraline Hcl	99	19
Trazodone Hcl	Trazodone Hcl	99	25
Buspirone Hcl	Buspirone Hcl	94	22
Pantoprazole Sodium	Pantoprazole Sodium	94	38
Citalopram Hbr	Citalopram Hydrobromide	85	13
Losartan Potassium	Losartan Potassium	84	30
Donepezil Hcl	Donepezil Hcl	78	20
Quetiapine Fumarate	Quetiapine Fumarate	78	19
Lantus	Insulin Glargine,hum.Rec.Anlog	76	14
Metoprolol Tartrate	Metoprolol Tartrate	74	35
Metformin Hcl	Metformin Hcl	73	16
Rosuvastatin Calcium	Rosuvastatin Calcium	70	suppressed
Bumetanide	Bumetanide	69	15
Carbidopa-Levodopa	Carbidopa/Levodopa	68	suppressed
Clopidogrel	Clopidogrel Bisulfate	68	20
Levetiracetam	Levetiracetam	63	11
Risperidone	Risperidone	61	suppressed
Simvastatin	Simvastatin	57	11
Famotidine	Famotidine	54	21
Prednisone	Prednisone	52	17
Fenofibrate	Fenofibrate Nanocrystallized	48	suppressed
Montelukast Sodium	Montelukast Sodium	45	suppressed
Spironolactone	Spironolactone	43	16
Fluticasone Propionate	Fluticasone Propionate	40	11
Glipizide Er	Glipizide	40	suppressed
Xarelto	Rivaroxaban	39	suppressed
Entresto	Sacubitril/Valsartan	38	suppressed
Cephalexin	Cephalexin	37	23
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	36	36
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	14
Finasteride	Finasteride	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Azelastine Hcl	Azelastine Hcl	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Atenolol	Atenolol	28	suppressed
Tradjenta	Linagliptin	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Olanzapine	Olanzapine	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Xifaxan	Rifaximin	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	22	suppressed
Calcium Acetate	Calcium Acetate	22	suppressed
Lithium Carbonate	Lithium Carbonate	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Lactulose	Lactulose	21	suppressed
Levofloxacin	Levofloxacin	21	16
Meloxicam	Meloxicam	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Allopurinol	Allopurinol	20	suppressed
Lorazepam	Lorazepam	20	13
Warfarin Sodium	Warfarin Sodium	20	suppressed
Xtandi	Enzalutamide	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Digoxin	Digoxin	18	suppressed
Humulin R	Insulin Regular, Human	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Combigan	Brimonidine Tartrate/Timolol	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Gemtesa	Vibegron	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Clonidine	Clonidine	15	suppressed
Haloperidol	Haloperidol	15	suppressed
Klayesta	Nystatin	15	12
Lumigan	Bimatoprost	15	suppressed
Mirabegron Er	Mirabegron	15	suppressed
Budesonide Ec	Budesonide	14	suppressed
Clozapine	Clozapine	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	14	suppressed
Permethrin	Permethrin	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error